Description
| Product Name | CAT.No | Size |
| PAPP-A | BXL0888A | 96T |
Product Description
The Biorex Diagnostics PAPP-A (Pregnancy-Associated Plasma Protein A) CLIA Kit is a quantitative chemiluminescent immunoassay (CLIA) designed for the precise measurement of PAPP-A concentrations in maternal serum or plasma. PAPP-A is a placental glycoprotein with a vital role in fetal development and maternal adaptation to pregnancy. Its levels provide essential clinical information during early gestation, making it a critical biomarker for prenatal screening and risk assessment, including evaluation for chromosomal abnormalities, preeclampsia, and other pregnancy-related complications.
The assay offers high sensitivity, specificity, and reproducibility, ensuring reliable detection of physiologically and clinically relevant concentrations throughout pregnancy. The microplate CLIA format enables multiple samples to be analyzed simultaneously, improving efficiency and workflow in clinical laboratories, prenatal care centers, and research facilities. The kit includes all necessary reagents, standards, and controls in a ready-to-use format, minimizing preparation errors and enhancing reproducibility across different operators and laboratory settings.
Key Features
- Quantitative CLIA Microplate Assay – provides accurate and precise measurement of maternal PAPP-A concentrations.
- High Sensitivity and Specificity – detects clinically relevant levels for prenatal assessment.
- Reliable Reproducibility – ensures consistent outcomes across multiple runs and laboratories.
- Ready-to-Use Kit Components – includes reagents, calibrators, and controls for streamlined workflow.
- Versatile Clinical and Research Applications – suitable for prenatal screening, obstetric evaluation, and maternal-fetal research studies.
Routine use of the kit allows healthcare professionals to assess early pregnancy status, monitor placental function, and evaluate potential risks for adverse pregnancy outcomes. By integrating this assay into prenatal screening protocols, clinicians can improve early detection of pregnancy complications, support informed decision-making, and optimize maternal-fetal health management. Additionally, the kit is suitable for research applications focused on placental biology, fetal development, and maternal adaptation to pregnancy.
Designed for hospitals, prenatal clinics, and clinical research laboratories, the Biorex Diagnostics PAPP-A CLIA Kit combines accuracy, speed, and ease of use to deliver reliable quantitative results. Its robust performance, reproducibility, and user-friendly design make it an essential tool for prenatal care, enabling high-quality diagnostics, enhanced patient monitoring, and improved pregnancy outcomes.
Contact Us for more information.